Hepatoprotective effect of silymarin. - Wikidata - wikimedia - TriplyDB

Hepatoprotective effect of silymarin.

Hepatoprotective effect of silymarin.

http://www.wikidata.org/entity/Q37646391

about

Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives Botanicals and Their Bioactive Phytochemicals for Women's Health A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage Protective effects of silymarin against bisphenol A-induced hepatotoxicity in mouse liver.Intraperitoneal Administration of Silymarin Protects End Organs from Multivisceral Ischemia/Reperfusion Injury in a Rat Model.The use of marine-derived bioactive compounds as potential hepatoprotective agents A 2-Week Course of Enteral Treatment with a Very Low-Calorie Protein-Based Formula for the Management of Severe Obesity.Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis: A Case Report and Literature Review.Pancreatic regeneration: basic research and gene regulation.Pharmacotherapy of alcoholic liver disease in clinical practice.Role of food-derived antioxidant agents against acetaminophen-induced hepatotoxicity.Silibinin: a potential old drug for cancer therapy.Silymarin and Its Role in Chronic Diseases.Effects of Silymarin on Diabetes Mellitus Complications: A Review.Effect of sılymarın on oxıdatıve stress and lıver hıstopathology ın experımental obstructıve jaundıce model.Protective Role of Silymarin on Hepatic and Renal Toxicity Induced by MTX Based Chemotherapy in Children with Acute Lymphoblastic Leukemia.Hepatoprotective effect of Geranium schiedeanum against ethanol toxicity during liver regeneration Protective effect of rutin in comparison to silymarin against induced hepatotoxicity in rats.Protective role of silymarin in a mouse model of renal Ischemia-Reperfusion injury.Protective effect of fucosterol isolated from the edible brown algae, Ecklonia stolonifera and Eisenia bicyclis, on tert-butyl hydroperoxide- and tacrine-induced HepG2 cell injury.Performance and serum biochemical profile of Japanese quail supplemented with silymarin and contaminated with aflatoxin B1.Protective Effect of Caffeic Acid Derivatives on tert-Butyl Hydroperoxide-Induced Oxidative Hepato-Toxicity and Mitochondrial Dysfunction in HepG2 Cells.Nanovesicle delivery to the liver via retinol binding protein and platelet-derived growth factor receptors: how targeting ligands affect biodistribution.Dietary silymarin supplementation promotes growth performance and improves lipid metabolism and health status in grass carp (Ctenopharyngodon idellus) fed diets with elevated lipid levels.Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance.A synergistic effect of Cremophor and beta glucosylceramide to exert liver and sugar protection.Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats.Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2 Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD

P2860

Q26767372-9B0EAB38-8859-41FF-9AF8-92E615006669 Q26770933-8D6B028F-EC9F-4E1B-8DE7-C2EBC7E68BA9 Q28065998-489C23BD-A738-4E62-AD41-1763CC68900B Q28546535-4D934920-290F-49C4-ACFC-3E9D8DCD439E Q28551489-B09AF3AF-0126-40F5-B999-580A185B48BC Q33598219-FD33AC2C-DDB6-4B63-816D-20407CDC5B98 Q33609312-B41FBBAC-27D4-4760-BC14-75BD943A47D1 Q35080141-60547230-C5A6-4229-84CE-252F8ECD41C2 Q35625824-AE50B3AB-C2FF-4B49-BE5F-15869025934A Q36234820-BE8F5106-267A-4D0E-B93C-A8C07E284FC4 Q37016845-D8E8866B-F6C5-4043-9DA2-29FB276A195F Q38543237-E8FC43BC-93F0-4E59-AB1C-55BF28C59A02 Q38681092-09C8A24F-19BA-4C63-893E-6D96E5AF856E Q38765827-129C84DC-ED97-47F1-9CCE-3E46C6EF584E Q38881726-DB20BF98-BCE1-4BF0-85B1-7D45B4156258 Q38988551-84F53E6A-0E78-420A-827D-16F05488904D Q38998120-EFEFCC7E-55A0-4801-B9F7-6C82B84E8FED Q39027008-9F2385BE-C763-41DB-A00B-475EE6185A9B Q41045039-738E142B-0C2B-434A-91A7-46B6F2C0980D Q41394103-4188EE99-303C-4E80-A81A-94FC1B328AFE Q42322587-9EE0567E-08CF-4043-8C89-89855B29641A Q43194413-440B8E88-D61B-42EA-BE49-4E9E5F05A334 Q46759156-18E68F42-2D76-4EE6-BAC0-EB9B293D867C Q47403566-9DF8794E-E28A-420C-BB6D-ABA92C08196E Q51030114-75A3BD84-CD78-4872-BB94-3284223CFC50 Q51197424-FC2E664D-967E-4B10-859F-52DEB3F5F00C Q51503602-5607A832-E187-445D-9431-71EB4E08E986 Q52098928-6CC90EC2-B198-4DDF-A1AA-834FC5EE90BE Q52644322-55377344-16AF-4F1D-BCA2-673A87179DB6 Q55014958-2EAD93CD-D1C8-4CE0-A167-4D5BA716EC9B Q55491306-3F06A169-8387-4B0A-B277-6BE5CD805282 Q57826028-A7473FD9-1CC7-4235-9876-93FFFBB7F0AE Q58707702-096EFB00-B7AF-4679-9A56-710C41E1CDA4 Q58765669-6D80F840-FAAA-4006-AF11-CB20B8DF7094

P2860

Hepatoprotective effect of silymarin.

http://www.wikidata.org/entity/Q37646391

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hepatoprotective effect of silymarin.

@en

Hepatoprotective effect of silymarin.

@nl

type

label

Hepatoprotective effect of silymarin.

@en

Hepatoprotective effect of silymarin.

@nl

prefLabel

Hepatoprotective effect of silymarin.

@en

Hepatoprotective effect of silymarin.

@nl

P1433

Q37646391-56569D5D-3322-4465-8BCA-A681DB9C05E5

P1476

Q37646391-831F85EC-CCDB-4550-BEF2-423955CB0964

P2093

Q37646391-3339C443-BC34-4725-82A3-62F6B49697E0

Q37646391-47B11448-B8A0-4DD1-8E43-07B9D1653331

Q37646391-4B4123B7-FC88-4691-A797-0BA439D1A414

Q37646391-551490EF-4F7A-48A7-8318-666FC121596F

Q37646391-5662FE5C-F2C7-46FA-90E8-26071DA1E334

Q37646391-6C8C74DD-17BF-4170-A907-201E89971106

Q37646391-B271E3D5-B492-4984-B65A-FAF903CBE386

Q37646391-DDB9B87C-A0C1-4FDF-97AB-B2ABBDF9B80D

P2860

Q37646391-05833CEE-921B-4DA8-B573-E6683513A36E

Q37646391-0E916071-4BEE-4781-9B25-6B90BAD6A44B

Q37646391-10165755-AD46-480D-93D5-B63EE3C1DC57

Q37646391-1A05BAA4-8AC6-4389-9F98-0AF342F1F526

Q37646391-236D3672-6C0D-4A7F-A34F-B06E9AA4E704

Q37646391-24095528-B50A-4FCF-8F9F-4EABDD4B8B0A

Q37646391-38EDB3D9-17FA-4808-89AE-47B2CCC96E9D

Q37646391-4B82F8A9-AE9D-4F1D-A6E1-49326E4F0BEC

Q37646391-540A69A3-325D-49C5-949F-E16447CDC038

Q37646391-5FC4836D-1E7C-409F-B479-37A9B3F46F2B

P304

Q37646391-C0D45AC8-6D29-44A8-B9D8-C0F1C2729E13

P31

Q37646391-F855DE59-0CB2-4451-B8B9-924893DCB23F

P356

Q37646391-4BA37DF2-9FC3-421C-9E41-6B0AF60D22E7

P433

Q37646391-7CF0B840-BBE0-4F1D-AA8A-2958534AB99D

P478

Q37646391-8983811A-9C17-436D-8FAF-BBDDE44E5589

P577

Q37646391-9CEE5742-F197-41A6-9F01-05531BC26F5A

P5875

Q37646391-2309BBFF-8EF1-489A-952E-EFE2CF376A1D

P698

Q37646391-D999E6CB-78B8-4D03-B8D3-DD01E3980C3A

P932

Q37646391-69F879B3-39CE-4F68-8707-0AA14B4A66D9

P356

P1433

World journal of hepatology

P1476

Hepatoprotective effect of silymarin.

@en

P2093

Angel Morales-González

http://www.w3.org/2001/XMLSchema#string

Cesar Esquivel-Chirino

http://www.w3.org/2001/XMLSchema#string

Eduardo Madrigal-Santillán

http://www.w3.org/2001/XMLSchema#string

Jaime Esquivel-Soto

http://www.w3.org/2001/XMLSchema#string

José A Morales-González

http://www.w3.org/2001/XMLSchema#string

Juan A Gayosso-de-Lucio

http://www.w3.org/2001/XMLSchema#string

Manuel García-Luna Y González-Rubio

http://www.w3.org/2001/XMLSchema#string

Nancy Vargas-Mendoza

http://www.w3.org/2001/XMLSchema#string

P2860

Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases

Identification of hepatoprotective flavonolignans from silymarin

Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region

Alcoholic liver disease: pathogenesis and new therapeutic targets.

Large-scale isolation of flavonolignans from Silybum marianum extract affords new minor constituents and preliminary structure-activity relationships.

Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin.

Silybin and the liver: from basic research to clinical practice.

"Silymarin", a promising pharmacological agent for treatment of diseases

Silymarin in non alcoholic fatty liver disease.

Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C

P304

144-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V6.I3.144

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261141010

http://www.w3.org/2001/XMLSchema#string

P698

24672644

http://www.w3.org/2001/XMLSchema#string

P932

3959115

http://www.w3.org/2001/XMLSchema#string